A comparative study to see the effectiveness of Pap smear, visual inspection with 3-5% acetic acid and its confirmation by cervical biopsy

Mili D. Choudhury; Sivaji S. Ghose; Milind Y. Dharmamer

doi:10.18203/2320-1770.ijrcog20200365

Authors

Mili D. Choudhury Department of Obstetrics and Gynecology, Naval Hospital Powai, Mumbai, Maharashtra, India
Sivaji S. Ghose Department of Surgery, Naval Hospital Powai, Mumbai, Maharashtra, India
Milind Y. Dharmamer Department of Anaesthesia, Naval Hospital Powai, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20200365

Keywords:

Acetic acid, Biopsy, Cancer, Cervix, Dysplasia, Mainstay, Pap smear, Squamous cell carcinoma

Abstract

Background: Cancer of the cervix is a leading cause of morbidity and mortality among women worldwide. The present study was undertaken to compare the effectiveness of Pap smear and visual inspection with 3-5% acetic acid (VIA) in screening carcinoma cervix followed by its confirmation by cervical biopsy.

Methods: A total of 100 patients with abnormal looking cervices or symptomatic patients having age beyond 30 years, attending the obstetrics and gynaecology OPD at Naval Hospital Powai, Mumbai from 31^st December 2015 to 31^st December 2017 were selected for the study. Pap smear and VIA was done on consecutive days. In positive cases cervical biopsy were done to confirm the result.

Results: The sensitivity of VIA was 100% but at the same time specificity was 41% there will be unnecessary investigation and biopsy in false positive cases. The sensitivity of cytology was 75% and specificity was 97%. Not a single case was missed by Pap smear only one case of severe dysplasia on cytology had squamous cell carcinoma on HPE which was done after 90 days because of delay in patients follow up.

Conclusions: Both the Pap smears and VIA is very effective screening tool for cervical cancer and histopathological examination remains the mainstay. But VIA is very cost effective and easy procedure, though it gives false positive reports but is not going to miss any case, rather leads to over diagnosis of the cases with cervicitis and hence treatment starts early and thus the progress of disease can be slowed down or even stopped.

Metrics

Metrics Loading ...

References

Ma X, Yu H. Global burden of cancer. Yale J Biol Med. 2006;79(3-4):85-94.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer J Clin. 2018;68(6):394-424.

Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women's cancers: a grand challenge in global health. Lancet. 2017;389(10071):847-60.

Hailemariam T, Yohannes B, Aschenaki H, Mamaye E, Orkaido G, Seta M. Prevalence of cervical cancer and associated risk factors among women attending cervical cancer screening and diagnosis center at Yirgalem General Hospital, Southern Ethiopia. J Cancer Sci Ther. 2017;9:730-5.

Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012;33(1):7-12.

Christopherson WM. Dysplasia, carcinoma in situ, and microinvasive carcinoma of the uterine cervix. Hum Pathol. 1977;8(5):489-501.

Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Ind J Med Paediatr Oncol. 2016;37(4):278-85.

Mishra GA, Pimple SA, Shastri SS. An overview of prevention and early detection of cervical cancers. Indian J Med Paediatr Oncol. 2011;32(3):125-32.

Das S, Mishra G, Paul S. Evaluation of cytology in unhealthy cervix. J Indian Med Asso. 1984;82:166.

Juneja A, Snehal A. A survey of risk factors associated with cervical cancer. Ind J Cancer. 2003;40:15-22.

Vaidya A. Comparison of PAP test among high risk and non-risk female. Kathmandu Univ Med J. 2003;1:18-3.

Donkoh ET, Agyemang-Yeboah F, Asmah RH, Wiredu EK. Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana. Med (Baltimore). 2019;98(13):e14600.

Bigerne and Johanson. 1983 cancer of cervix edited by Hugh M Shinyele Ton and James W Orr. 1st edition; 1987.

Boyes DA, Worth AJ. Treatment of early cervical neoplasia: definition and management of pre-clinical invasive carcinoma. Gynecol Oncol. 1981;12:317-30.

Arbyn M, Sankaranarayanan R, Munwongs R, Keita N, Dolo A. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J cancer 2008;123:153-60.

Saleh HS. Can visual inspection with acetic acid be used as an alternative to Pap smear in screening cervical cancer? Middle East Fertil Soc J. 2014;19:187-91.

Sankaranarayanan R, Wesley R, Somanathan T, Dhakad N, Shyamalakumary B, Amma NS, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer: Interdi Int J Am Cancer Soc. 1998;83(10):2150-6.

Consul S, Agrawal A, Sharma H, Bansal A, Gutch M, Jain N. Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid and visual inspection with Lugol's iodine for mass screening of premalignant and malignant lesion of cervix. Indian J Med Paediatr Oncol. 2012;33:161-5.

Pandey K, Bhagoliwal A. Cancer cervix - need for mass surveillance program specially in rural areas. J Obst Gynecol India. 2005;55(5):1-5.

Nene BM, Deshpande S, Kasturi J, Budukh AM, Dale PS, Deshpande DA, et al. Early detection of cervical cancer by visual inspection: A population‐based study in rural India. Int J Cancer. 1996;68(6):770-3.

Upreti S, Shanker R, Subramanian J, Rohtagi P. A study of cervical dysplasia and its relation with various factors. J Obst Gynecol India. 1981;834-6.

Saraiya U, Lula M. Evaluation of cervical lesion by combined use of cytology, colposcopy and histology. J Obst Gyne. 1984-1998.

Bhattacharyya AK, Nath JD, and Deka H. Comparative study between pap smear and visual inspection with acetic acid (via) in screening of CIN and early cervical cancer. J Midlife Health. 2015;6(2):53-8.